Epstein-Barr Virus: Activation of WNT

Epstein-Barr 病毒:WNT 激活

基本信息

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to characterize the effects of Epstein Barr Virus (EBV) on the Writ/Wingless signaling pathway which is a critical regulator of cell growth and differentiation during development and is frequently affected during cancer development. In this application, we will determine if this pathway is activated infected cell lines and in EBV-associated cancers, identify the viral proteins that affect regulation of this pathway, determine the mechanisms that underlie this activation, and identify the cellular targets that are affected by this activation. Specifically we will: 1) Characterize beta-catenin levels, localization, and activity in EBV positive and negative cell lines and in EBV-associated and AIDS-related cancers using cell fractionation and immunoblotting, electrophoretic mobility shift assays (EMSA) on beta-catenin responsive elements, reporter assays, and immunohistochemistry to identify specific phosphorylated protein components of the pathway and determine intracellular localization of beta-catenin. 2) Identify the effects of LMP 1 on expression and localization of components of writ/wingless using protein and gene array analyses. 3) Determine the effects of LMP2 on Akt activation, inactivation of glycogen synthase kinase beta, B-catenin localization, and wnt-regulated gene expression. Compare and contrast LMP2 with mutated forms of LMP2 and with constitutively activated forms of PI3-kinase and Akt. Determine the contribution of activation of this pathway on LMP2-mediated effects on cellular growth using fibroblast and epithelial cell transformation assays and perform genomic expression array analysis on cell lines expressing LMP2, mutant forms of LMP2, or activated components of wnt signaling to determine effects on gene expression. 4) Analyze LEF/TCF regulated gene expression in cell lines expressing EBV latent proteins. Identify components of the transcription complex and determine how EBV proteins affect this complex. The proposed studies represent the first studies on a completely new pathway likely affected in EBV-associated cancers. These studies will determine the contribution of this pathway in the development of EBV-associated cancers and identify the specific effects of EBV proteins on the regulation of wnt/wingless signaling. A detailed understanding of the activation of this pathway may provide new opportunities for treatment of EBV-associated cancers and also of similar cancers considered EBV-negative, that develop in the immunosuppressed.
描述(由申请方提供):本提案的目的是表征爱泼斯坦巴尔病毒(EBV)对Writ/Wingless信号通路的影响,Writ/Wingless信号通路是发育期间细胞生长和分化的关键调节因子,在癌症发展期间经常受到影响。在本申请中,我们将确定该途径是否在感染细胞系和EBV相关癌症中被激活,鉴定影响该途径调节的病毒蛋白,确定该激活的机制,并鉴定受该激活影响的细胞靶点。具体而言,我们将:1)使用细胞分级分离和免疫印迹、对β-连环蛋白应答元件的电泳迁移率变动测定(EMSA)、报告基因测定和免疫组织化学来表征EBV阳性和阴性细胞系以及EBV相关和AIDS相关癌症中的β-连环蛋白水平、定位和活性,以鉴定途径的特异性磷酸化蛋白组分并确定β-连环蛋白的细胞内定位。2)使用蛋白质和基因阵列分析确定LMP 1对writ/wingless组分的表达和定位的影响。3)确定LMP 2对Akt激活、糖原合成酶激酶β失活、B-连环蛋白定位和wnt调节的基因表达的影响。比较和对比LMP 2与LMP 2的突变形式以及PI 3-激酶和Akt的组成性激活形式。使用成纤维细胞和上皮细胞转化试验确定该途径的激活对LMP 2介导的细胞生长效应的贡献,并对表达LMP 2、LMP 2突变形式或wnt信号传导的活化组分的细胞系进行基因组表达阵列分析,以确定对基因表达的影响。4)分析表达EBV潜伏蛋白的细胞系中LEF/TCF调节的基因表达。识别转录复合物的组成部分,并确定EBV蛋白如何影响该复合物。拟议的研究代表了对可能影响EBV相关癌症的全新途径的首次研究。这些研究将确定该途径在EBV相关癌症发展中的作用,并确定EBV蛋白对wnt/wingless信号转导调控的特异性作用。详细了解这种途径的激活可能为治疗EBV相关癌症以及在免疫抑制中发展的EBV阴性的类似癌症提供新的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY JOAN RAAB-TRAUB其他文献

NANCY JOAN RAAB-TRAUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY JOAN RAAB-TRAUB', 18)}}的其他基金

Virology
病毒学
  • 批准号:
    8340212
  • 财政年份:
    2011
  • 资助金额:
    $ 31.72万
  • 项目类别:
Virology
病毒学
  • 批准号:
    8340213
  • 财政年份:
    2011
  • 资助金额:
    $ 31.72万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8386652
  • 财政年份:
    2009
  • 资助金额:
    $ 31.72万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8585832
  • 财政年份:
    2009
  • 资助金额:
    $ 31.72万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    7785008
  • 财政年份:
    2009
  • 资助金额:
    $ 31.72万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    7995263
  • 财政年份:
    2009
  • 资助金额:
    $ 31.72万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8196870
  • 财政年份:
    2009
  • 资助金额:
    $ 31.72万
  • 项目类别:
Herpesviral Oncogenesis, Latency and Reactivation
疱疹病毒肿瘤发生、潜伏期和再激活
  • 批准号:
    7908032
  • 财政年份:
    2009
  • 资助金额:
    $ 31.72万
  • 项目类别:
ADMINISTRATION CORE
管理核心
  • 批准号:
    6930192
  • 财政年份:
    2005
  • 资助金额:
    $ 31.72万
  • 项目类别:
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2
EBV 潜伏膜蛋白 1 和 2 的转化
  • 批准号:
    6930190
  • 财政年份:
    2005
  • 资助金额:
    $ 31.72万
  • 项目类别:

相似海外基金

Analysis of transmembrane proteins activity in urological cancers using humanized SCID mouse
使用人源化 SCID 小鼠分析泌尿系统癌症中的跨膜蛋白活性
  • 批准号:
    19K09674
  • 财政年份:
    2019
  • 资助金额:
    $ 31.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SCID Mouse: Human Xenograft Core
SCID 小鼠:人类异种移植核心
  • 批准号:
    7608570
  • 财政年份:
    2008
  • 资助金额:
    $ 31.72万
  • 项目类别:
SCID Mouse : Human Xenograft Core
SCID 小鼠:人类异种移植核心
  • 批准号:
    7392297
  • 财政年份:
    2007
  • 资助金额:
    $ 31.72万
  • 项目类别:
Core B - SCID Mouse : Human Xenograft Core (Jordan Pober, MD/PhDP.I.)
核心 B - SCID 小鼠:人类异种移植核心(Jordan Pober,医学博士/博士)
  • 批准号:
    6756347
  • 财政年份:
    2004
  • 资助金额:
    $ 31.72万
  • 项目类别:
CORE--NOD/SCID MOUSE
核心--NOD/SCID鼠标
  • 批准号:
    6967796
  • 财政年份:
    2004
  • 资助金额:
    $ 31.72万
  • 项目类别:
EXPERIMENTAL ANALYSIS OF VASCULER CHANGES IN CHRONIC ALLOGRAFT REJECTION USING HUMANIZED SCID MOUSE MODEL.
使用人源化 SCID 小鼠模型对慢性同种异体移植排斥中的血管变化进行实验分析。
  • 批准号:
    14571526
  • 财政年份:
    2002
  • 资助金额:
    $ 31.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The heat shock protein(HSP) was investigated as the pathogenesis of focal infection with tonsil by the SCID mouse model
通过SCID小鼠模型研究热休克蛋白(HSP)作为扁桃体局灶性感染的发病机制
  • 批准号:
    14571629
  • 财政年份:
    2002
  • 资助金额:
    $ 31.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues.
通过原位植入手术切除的肺癌组织的原代培养细胞建立类患者 SCID 小鼠模型。
  • 批准号:
    14571269
  • 财政年份:
    2002
  • 资助金额:
    $ 31.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CORE--NUDE/SCID MOUSE FACILITY
核心——NUDE/SCID 小鼠设施
  • 批准号:
    6563716
  • 财政年份:
    2001
  • 资助金额:
    $ 31.72万
  • 项目类别:
CORE--NOD/SCID MOUSE
核心--NOD/SCID鼠标
  • 批准号:
    6496710
  • 财政年份:
    2001
  • 资助金额:
    $ 31.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了